Coralia Bleotu

Dr. Coralia Bleotu

Stefan S Nicolau Institute of Virology
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2019 in World Journal of Gastroenterology
Verified
Journal Article
Open access
LNLaura Necula
Laura Necula
LMLilia Matei
Lilia Matei
DDDenisa Dragu
Denisa Dragu
ANAna I Neagu
Ana I Neagu
CMCristina Mambet
Cristina Mambet
MEMihaela Economescu
Mihaela Economescu
Recent advances in gastric cancer early diagnosis

1 January 2015 in World Journal of Stem Cells
Verified
Journal Article
Open access
DDDenisa L Dragu
Denisa L Dragu
MEMihaela Economescu
Mihaela Economescu
CDCarmen Cristina Diaconu
Carmen Cristina Diaconu
Coralia BleotuCoralia Bleotu
Coralia Bleotu
LNLaura G Necula
Laura G Necula
Therapies targeting cancer stem cells: Current trends and future challenges

6 May 2020 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
Corneliu Ovidiu VrancianuCorneliu Ovidiu Vrancianu
Corneliu Ovidiu Vrancianu
LPLaura Ioana Popa
Laura Ioana Popa
Coralia BleotuCoralia Bleotu
Coralia Bleotu
MCMariana Carmen Chifiriuc
Mariana Carmen Chifiriuc
Antimicrobial resistance (AMR) is a significant global threat to both public health and the environment. The emergence and expansion of AMR is sustained by the enormous diversity and mobility of antimicrobial resistance genes (ARGs). Different mechanisms of horizontal gene transfer (HGT), including conjugation, transduction, and transformation, have facilitated the accumulation and dissemination of ARGs in Gram-negative and Gram-positive bacteria. This has resulted in the development of multidrug resistance in some bacteria. The most clinically significant ARGs are usually located on different mobile genetic elements (MGEs) that can move intracellularly (between the bacterial chromosome and plasmids) or intercellularly (within the same species or between different species or genera). Resistance plasmids play a central role both in HGT and as support elements for other MGEs, in which ARGs are assembled by transposition and recombination mechanisms. Considering the crucial role of MGEs in the acquisition and transmission of ARGs, a potential strategy to control AMR is to eliminate MGEs. This review discusses current progress on the development of chemical and biological approaches for the elimination of ARG carriers.

1 May 2015 in Pancreatology
Verified
Journal Article
Closed access
MBMircea Beuran
Mircea Beuran
Ionut NegoiIonut Negoi
Ionut Negoi
SPSorin Paun
Sorin Paun
AIAdriana Daniela Ion
Adriana Daniela Ion
Coralia BleotuCoralia Bleotu
Coralia Bleotu
Sorin HostiucSorin Hostiuc
Sorin Hostiuc

Verified
Journal Article
Open access
PDF file
LNLaura Necula
Laura Necula
LMLilia Matei
Lilia Matei
LDLaura Denisa Dragu
Laura Denisa Dragu
IPIoana Madalina Pitica
Ioana Madalina Pitica
ANAna Neagu
Ana Neagu
MEMihaela Economescu
Mihaela Economescu
Despite advances in cancer detection and therapy, it has been estimated that the incidence of cancers will increase, while the mortality rate will continue to remain high, a fact explained by the large number of patients diagnosed in advanced stages when therapy is often useless. Therefore, it is necessary to invest knowledge and resources in the development of new non-invasive biomarkers for the early detection of cancer and new therapeutic targets for better health management. In this review, we provided an overview on the collagen family as promising biomarkers and on how they may be exploited as therapeutic targets in cancer. The collagen family tridimensional structure, organization, and functions are very complex, being in a tight relationship with the extracellular matrix, tumor, and immune microenvironment. Moreover, accumulating evidence underlines the role of collagens in promoting tumor growth and creating a permissive tumor microenvironment for metastatic dissemination. Knowledge of the molecular basis of these interactions may help in cancer diagnosis and prognosis, in overcoming chemoresistance, and in providing new targets for cancer therapies.

1 June 2010 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
CTC. Tanasescu
C. Tanasescu
EBE. Balanescu
E. Balanescu
PBP. Balanescu
P. Balanescu
ROR. Olteanu
R. Olteanu
CBC. Badea
C. Badea
AGA. Georgescu
A. Georgescu